A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio

BACKGROUND: Subcutaneous allergen immunotherapy (SCIT) with depigmented, polymerized (DPP) birch pollen extract has been marketed at doses of up to 1000 DPP units/mL since 2001. We sought to determine the dose‐dependent efficacy of a DPP birch pollen extract formulation in patients suffering from bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaar, Oliver, Sager, Angelika, Mösges, Ralph, Worm, Margitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646866/
https://www.ncbi.nlm.nih.gov/pubmed/38006380
http://dx.doi.org/10.1002/clt2.12315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646866/
https://www.ncbi.nlm.nih.gov/pubmed/38006380
http://dx.doi.org/10.1002/clt2.12315

Ejemplares similares